A detailed history of O'Brien Greene & Co. Inc transactions in Johnson & Johnson stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 6,996 shares of JNJ stock, worth $1.02 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
6,996
Previous 9,567 26.87%
Holding current value
$1.02 Million
Previous $1.4 Million 18.96%
% of portfolio
0.37%
Previous 0.46%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$145.48 - $167.38 $374,029 - $430,333
-2,571 Reduced 26.87%
6,996 $1.13 Million
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $115,070 - $125,750
797 Added 9.09%
9,567 $1.4 Million
Q2 2023

Aug 15, 2023

SELL
$154.35 - $166.11 $2.71 Million - $2.91 Million
-17,540 Reduced 66.67%
8,770 $1.45 Million
Q2 2023

Jul 20, 2023

BUY
$154.35 - $166.11 $2.71 Million - $2.91 Million
17,540 Added 200.0%
26,310 $4.36 Million
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $2.92 Million - $3.28 Million
-18,236 Reduced 67.53%
8,770 $1.55 Million
Q3 2022

Nov 09, 2022

BUY
$161.33 - $179.52 $2.9 Million - $3.23 Million
18,003 Added 199.97%
27,006 $4.41 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $43,393 - $47,990
-258 Reduced 2.79%
9,003 $1.6 Million
Q1 2022

May 18, 2022

SELL
$158.14 - $179.59 $80,967 - $91,950
-512 Reduced 5.24%
9,261 $1.64 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $58,785 - $65,224
-377 Reduced 3.71%
9,773 $1.67 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $4.3 Million - $4.78 Million
-26,628 Reduced 72.4%
10,150 $1.64 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $250,383 - $268,579
1,570 Added 4.46%
36,778 $6.06 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $111,128 - $123,768
726 Added 2.11%
35,208 $5.79 Million
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $369,511 - $424,139
2,695 Added 8.48%
34,482 $5.43 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $27,233 - $29,843
-194 Reduced 0.61%
31,787 $4.73 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $30,656 - $37,011
-238 Reduced 0.74%
31,981 $4.5 Million
Q1 2020

May 07, 2020

SELL
$111.14 - $153.99 $13,336 - $18,478
-120 Reduced 0.37%
32,219 $4.22 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $233,325 - $267,985
-1,830 Reduced 5.36%
32,339 $4.72 Million
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $210,737 - $235,952
-1,660 Reduced 4.63%
34,169 $4.42 Million
Q2 2019

Aug 21, 2019

SELL
$131.15 - $144.24 $37,640 - $41,396
-287 Reduced 0.79%
35,829 $4.99 Million
Q1 2019

Apr 29, 2019

SELL
$125.72 - $139.79 $8,171 - $9,086
-65 Reduced 0.18%
36,116 $5.05 Million
Q4 2018

Feb 27, 2019

BUY
$122.84 - $147.84 $4.44 Million - $5.35 Million
36,181 New
36,181 $4.67 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track O'Brien Greene & Co. Inc Portfolio

Follow O'Brien Greene & Co. Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Greene & Co. Inc with notifications on news.